{"title":"Clinicopathological difference between invasive pancreatic duct cancer and distal bile duct cancer of the pancreas head after pancreaticoduodenectomy","authors":"M. Ikeguchi, K. Endo","doi":"10.5348/100090z04mi2020ra","DOIUrl":null,"url":null,"abstract":"Aims: The only curative treatment for patients with invasive pancreatic duct cancer (IPDC) and distal bile duct cancer (DBDC) of the pancreas head is pancreaticoduodenectomy (PD). However, the clinicopathological difference between IPDC and DBDC after PD has not been thoroughly discussed. In this study, we retrospectively analyzed the clinical and pathological difference between IPDC and DBDC in patients who underwent PD. Methods: Sixty-six patients who underwent curative PD were enrolled (IPDC, n = 35; DBDC, n = 31). Preoperative, intraoperative, and postoperative parameters and pathological factors (stages, lymph node metastasis, lymphatic invasion, vascular invasion, and perineural invasion) were compared. Results: Jaundice was frequently detected and preoperative biliary drainage was frequently performed in patients with DBDC (60.5% and 90.3%, respectively). Additionally, the preoperative serum total bilirubin concentration and C-reactive protein/albumin ratio were higher in patients with DBDC than IPDC. As a result, the occurrence of postoperative pancreatic fistula occurred more frequently in patients with DBDC. In contrast, lymph node metastasis, lymphatic invasion, and vascular invasion were detected more frequently in patients with IPDC. The overall 5-year survival rate of the 35 patients with IPDC (13.4%) was much worse than that of the 31 patients with DBDC (52.3%, p < 0.001). Masahide Ikeguchi1, Kanenori Endo2 Affiliations: 1Department of Surgery, Kitaoka Hospital, 10315 Meiji-machi, Kurayoshi, Japan; 2Department of Surgery, Tottori Prefectural Central Hospital, 730 Ezu, Tottori, Japan. Corresponding Author: Masahide Ikeguchi, MD, Department of Surgery, Kitaoka Hospital, 1031-5 Meiji-machi, Kurayoshi 682-0887, Japan; Email: m-ikeguchi@kitaokahp.jp Received: 07 May 2020 Accepted: 27 June 2020 Published: 07 August 2020 RE ARCH ARTICLE PEER REVIEWED | OPEN A CE S Conclusion: The oncological characteristics of IPDC are much different from those of DBDC. More effective treatment should be started in patients with IPDC as soon as possible.","PeriodicalId":40532,"journal":{"name":"International Journal of Hepatobiliary and Pancreatic Diseases","volume":"10 1","pages":"1"},"PeriodicalIF":0.2000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Hepatobiliary and Pancreatic Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5348/100090z04mi2020ra","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Aims: The only curative treatment for patients with invasive pancreatic duct cancer (IPDC) and distal bile duct cancer (DBDC) of the pancreas head is pancreaticoduodenectomy (PD). However, the clinicopathological difference between IPDC and DBDC after PD has not been thoroughly discussed. In this study, we retrospectively analyzed the clinical and pathological difference between IPDC and DBDC in patients who underwent PD. Methods: Sixty-six patients who underwent curative PD were enrolled (IPDC, n = 35; DBDC, n = 31). Preoperative, intraoperative, and postoperative parameters and pathological factors (stages, lymph node metastasis, lymphatic invasion, vascular invasion, and perineural invasion) were compared. Results: Jaundice was frequently detected and preoperative biliary drainage was frequently performed in patients with DBDC (60.5% and 90.3%, respectively). Additionally, the preoperative serum total bilirubin concentration and C-reactive protein/albumin ratio were higher in patients with DBDC than IPDC. As a result, the occurrence of postoperative pancreatic fistula occurred more frequently in patients with DBDC. In contrast, lymph node metastasis, lymphatic invasion, and vascular invasion were detected more frequently in patients with IPDC. The overall 5-year survival rate of the 35 patients with IPDC (13.4%) was much worse than that of the 31 patients with DBDC (52.3%, p < 0.001). Masahide Ikeguchi1, Kanenori Endo2 Affiliations: 1Department of Surgery, Kitaoka Hospital, 10315 Meiji-machi, Kurayoshi, Japan; 2Department of Surgery, Tottori Prefectural Central Hospital, 730 Ezu, Tottori, Japan. Corresponding Author: Masahide Ikeguchi, MD, Department of Surgery, Kitaoka Hospital, 1031-5 Meiji-machi, Kurayoshi 682-0887, Japan; Email: m-ikeguchi@kitaokahp.jp Received: 07 May 2020 Accepted: 27 June 2020 Published: 07 August 2020 RE ARCH ARTICLE PEER REVIEWED | OPEN A CE S Conclusion: The oncological characteristics of IPDC are much different from those of DBDC. More effective treatment should be started in patients with IPDC as soon as possible.
目的:胰头浸润性胰管癌(IPDC)和远端胆管癌(DBDC)的唯一治疗方法是胰十二指肠切除术(PD)。然而,PD后IPDC和DBDC的临床病理差异尚未得到充分讨论。在本研究中,我们回顾性分析了PD患者IPDC和DBDC的临床和病理差异。方法:66例治疗性PD患者(IPDC, n = 35;DBDC, n = 31)。比较术前、术中、术后参数及病理因素(分期、淋巴结转移、淋巴浸润、血管浸润、神经周围浸润)。结果:DBDC患者黄疸发生率高,术前胆道引流发生率高(分别为60.5%和90.3%)。此外,DBDC患者术前血清总胆红素浓度和c反应蛋白/白蛋白比值高于IPDC患者。因此,DBDC患者术后胰瘘的发生率更高。相比之下,淋巴结转移、淋巴浸润和血管浸润在IPDC患者中更为常见。35例IPDC患者的总5年生存率(13.4%)明显低于31例DBDC患者的总5年生存率(52.3%,p < 0.001)。附属单位:1北冈医院外科学,日本仓利市明治町10315;2鸟取县中心医院外科,鸟取县Ezu 730,日本。通讯作者:Masahide Ikeguchi,医学博士,北冈医院外科,1031-5 Meiji-machi, Kurayoshi 682-0887,日本;Email: m-ikeguchi@kitaokahp.jp收稿日期:2020年5月07日收稿日期:2020年6月27日发布日期:2020年8月07日研究论文同行评审| OPEN A CE S结论:IPDC与DBDC的肿瘤特征有很大不同。IPDC患者应尽快开始更有效的治疗。